The Effect of Pomegranate Peel, German Chamomile or Their Combination on Gingivitis

Sponsor
Alexandria University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05951647
Collaborator
(none)
60
1
5
3.7
16.2

Study Details

Study Description

Brief Summary

The aim of this study is to compare clinically and biochemically the effect of herbal mouthwashes containing German chamomile and pomegranate peel extracts individually and as a mixture to chlorohexidine mouthwash in the treatment of gingivitis. The response will be assessed clinically and by suitable biochemical parameters.

Condition or Disease Intervention/Treatment Phase
  • Drug: Chamomile extract mouthwash
  • Drug: Pomegranate peel extract mouth wash
  • Drug: Combination of 5% chamomile extract and pomegranate peel extract mouthwash
  • Procedure: Scaling
  • Drug: Scaling and Chlorohexidine mouthwash
Phase 3

Detailed Description

  1. Ethical committee approval has been obtained from Ethics committee of Faculty of Medicine and Faculty of Dentistry, Alexandria University

  2. All participants should agree to take part in this clinical study and will provide informed consent.

  3. Sixty plaque induced gingivitis patients ,will be recruited from Faculty of Dentistry, Alexandria University.

  4. The 60 participants will be randomly assigned into 5 groups. Group 1: Patients will be managed by scaling. Group 2: Patients will be managed by scaling and will use 0.12%% chlorohexidine mouthwash in a dose of 15 ml twice daily.

Group 3: Patients will be managed by scaling and will use 5% chamomile extract mouthwash in a dose of 15 ml twice daily.

Group 4: Patients will be managed by scaling and will use 5% pomegranate peel extract mouth wash in a dose of 15 ml twice daily.

Group 5: Patients will be managed by scaling and will use a combination of 5% chamomile extract and pomegranate peel extract mouthwash in a dose of 15 ml twice daily.

  1. All patients will be submitted to:
  • Full patient history and clinical examination.

  • Gingival index will be measured

  • Saliva samples will be obtained in order to conduct ELISA for the selected biomarkers.

  • Different mouthwashes will be provided to patients.

  1. Statistical tests appropriate to the study design will be conducted to evaluate the significance of the results.

  2. Results, conclusion, discussion and recommendations will be given.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Double-blinded, parallel, randomized clinical trialDouble-blinded, parallel, randomized clinical trial
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
The Effect of Mouthwashes Containing Pomegranate Peel, German Chamomile or Their Combination in the Treatment of Gingivitis
Anticipated Study Start Date :
Jul 11, 2023
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Scaling

12 patients will be managed by scaling only

Procedure: Scaling
Patients will be managed by scaling

Active Comparator: Scaling and Chlorohexidine mouthwash

Patients will be managed by scaling and will use 0.12%% chlorohexidine mouthwash in a dose of 15 ml twice daily.

Drug: Scaling and Chlorohexidine mouthwash
scaling and will use 0.12%% chlorohexidine mouthwash in a dose of 15 ml twice daily.

Experimental: Scaling and Chamomile extract mouthwash

Patients will be managed by scaling and will use 5% chamomile extract mouthwash in a dose of 15 ml twice daily.

Drug: Chamomile extract mouthwash
5% chamomile extract mouthwash in a dose of 15 ml twice daily.

Experimental: Scaling and Pomegranate peel extract mouthwash

Patients will be managed by scaling and will use 5% pomegranate peel extract mouth wash in a dose of 15 ml twice daily.

Drug: Pomegranate peel extract mouth wash
5% pomegranate peel extract mouth wash in a dose of 15 ml twice daily.

Experimental: Scaling and Chamomile extract mixed with Pomegranate peel extract mouthwash

Patients will be managed by scaling and will use a combination of 5% chamomile extract and pomegranate peel extract mouthwash in a dose of 15 ml twice daily.

Drug: Combination of 5% chamomile extract and pomegranate peel extract mouthwash
Use a combination of 5% chamomile extract and pomegranate peel extract mouthwash in a dose of 15 ml twice daily.

Outcome Measures

Primary Outcome Measures

  1. Clinical assessment for the gingival index (GI) [15 days]

    The gingival index will measured before treatment, 7 days, and 15 days after treatment respectively.

Secondary Outcome Measures

  1. Measurement of TNF-α saliva level [15 days]

    TNF-α saliva level will be measured before treatment, 7 days, and 15 days after treatment respectively.

  2. Measurement of IL1β saliva level [15 days]

    IL1β saliva level will be measured before treatment, 7 days, and 15 days after treatment respectively.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age: 25-50

  • Patients with plaque induced gingivitis.

Exclusion Criteria:
  • Patients with systemic diseases (diabetes, leukemia, anemia)

  • Smokers

  • Pregnant females

  • Patients receiving orthodontic treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Pharmacy, Alexandria University Alexandria Egypt 21521

Sponsors and Collaborators

  • Alexandria University

Investigators

  • Principal Investigator: Eman Sh Anwar, PhD, Faculty of Pharmacy, Alexandria University
  • Principal Investigator: Maha R Taalab, PhD, Alexandria University
  • Principal Investigator: Doaa A Ghareeb, PhD, Faculty of Science, Alexandria University
  • Principal Investigator: Noha A Hamdy, PhD, Faculty of Pharmacy, Alexandria University
  • Principal Investigator: Marwa A Alashwah, PharmD, Faculty of Pharmacy, Alexandria University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alexandria University
ClinicalTrials.gov Identifier:
NCT05951647
Other Study ID Numbers:
  • 0107722
First Posted:
Jul 19, 2023
Last Update Posted:
Jul 19, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Alexandria University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2023